VIDEO: Medical ganja company targets $4b in revenue by 2019; eyes IPO by 1Q next year....said the executive chairman of Medicanja Limited, Dr Henry Lowe. "This will give Jamaicans at home and in the Diaspora a chance to invest"....."We are talking big business, not monkey money," said former Prime Minister P J Patterson, who is a member of the Medicanja board.

BY TERRON DEWAR Caribbean Business reporter  dewart@jamaicaobserver.com  Friday, October 31, 2014    

LOCAL medical marijuana company, Medicanja Limited, expects to generate approximately $4 billion in sales within four years.

Executive chairman of Medicanja Limited, Dr Henry Lowe.

"Revenue from the sales and services of over 18 products that we have planned from Medicanja limited, including six product lines, will be in excess of $4 billion," said the executive chairman of Medicanja Limited, Dr Henry Lowe.

What's more, during the first quarter of next year, Medicanja plans to launch an initial public offering (IPO) to raise funds from the market to continue product development and research.

"This will give Jamaicans at home and in the Diaspora a chance to invest" in a product that shares a strong brand association with the country, he said.

On Wednesday, the company launched seven new products that will hit the market in December.

VIDEO: Medical ganja company targets $4b
 in revenue by 2019; eyes IPO by 1Q next year

The products are among the first in a line of 18 pharmaceutical and nutraceutical items that the company plans to bring to market over the course of the next year.

'The magnificent seven', as the first line of products are called, was designed to help with the 'pain management of some 84 ailments using products such as marijuana-based rubbing alcohol (CanjaCol), healing oil (CanjaRub), pain-relief spray (CanjaSol), anti-inflammatory cream (CanjaFlam), Arthritis cream (CanjaSolve), sublingual drop (CanjaRelief) and nausea relief sprays (CanjaSure). more